Search Results - "Miyagawa, Jun‐Ichiro"

Refine Results
  1. 1
  2. 2
  3. 3

    Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus by Katsuno, Tomoyuki, Ikeda, Hiroki, Ida, Kenichi, Miyagawa, Jun-ichiro, Namba, Mitsuyoshi

    Published in Endocrine Journal (2013)
    “…The effect of add-on therapy with sitagliptin on glycemic control was prospectively investigated in patients with type 2 diabetes mellitus (T2DM) receiving…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Significance of the regulation of hyperglucagonemia in type 2 diabetes mellitus by Miuchi, Masayuki, Miyagawa, Jun-ichiro, Namba, Mitsuyoshi

    Published in Nihon rinshō (01-12-2015)
    “…Abstract Generally, pancreatic β-cell dysfunction and hypoinsulinemia have been known as the cause of development of hyperglycemia in diabetes mellitus…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes by Tokuda, Masaru, Katsuno, Tomoyuki, Ochi, Fumihiro, Miyakoshi, Kana, Kusunoki, Yoshiki, Murai, Kazuki, Miuchi, Masayuki, Hamaguchi, Tomoya, Miyagawa, Jun-ichiro, Namba, Mitsuyoshi

    Published in Endocrine Journal (2014)
    “…The effects of exenatide on glycemic control, lipid metabolism, blood pressure, and gastrointestinal symptoms were investigated in obese Japanese patients with…”
    Get full text
    Journal Article
  13. 13
  14. 14

    New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy by Namba, Mitsuyoshi, Katsuno, Tomoyuki, Kusunoki, Yoshiki, Matsuo, Toshihiro, Miuchi, Masayuki, Miyagawa, Jun-ichiro

    Published in Clinical and experimental nephrology (01-02-2013)
    “…Incretin-based therapy was first made available for the treatment of type 2 diabetes mellitus (T2DM) in the US in 2006 and in Japan in 2009. Four DPP-4…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Incretin-based therapy in patients with type 1 diabetes mellitus by Miyagawa, Jun-Ichiro, Miuchi, Masayuki, Namba, Mitsuyoshi

    Published in Nihon rinshō (01-05-2011)
    “…GLP-1 has multiple physiological functions including glucose-dependent insulin secretion and glucagon suppression, delay of gastic emptying, suppression of…”
    Get more information
    Journal Article